Allen v. Minnesota Life Insurance

216 F. Supp. 2d 1377, 2001 U.S. Dist. LEXIS 10460, 2001 WL 1898261
CourtDistrict Court, N.D. Georgia
DecidedFebruary 28, 2001
Docket1:99-cv-01610
StatusPublished
Cited by7 cases

This text of 216 F. Supp. 2d 1377 (Allen v. Minnesota Life Insurance) is published on Counsel Stack Legal Research, covering District Court, N.D. Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Allen v. Minnesota Life Insurance, 216 F. Supp. 2d 1377, 2001 U.S. Dist. LEXIS 10460, 2001 WL 1898261 (N.D. Ga. 2001).

Opinion

ORDER

FORRESTER, District Judge.

This matter is before the court on cross motions for summary judgment.

I. STATEMENT OF THE CASE

A. Procedural History

Plaintiff, Robert Lee Allen, filed the instant action in the Superior Court of Fulton County, Georgia on April 30, 1999. Plaintiff alleges that Defendant, Minnesota Life Insurance Company, breached a contract by terminating benefits to Plaintiff under an insurance policy issued by Defendant. Plaintiff further alleges that Defendant acted in bad faith. In addition to damages, Plaintiff seeks declaratory relief, attorney fees, and costs. Invoking this court’s diversity jurisdiction, Defendant removed the case to this court pursuant to 28 U.S.C. §§ 1441 and 1446 on June 21, 1999. Following discovery, the parties filed the instant motions for summary judgment.

B. Facts 1

Plaintiff received his medical degree from the Medical College of Virginia in 1989. After receiving his degree, Plaintiff then participated in a postdoctoral residency in anesthesiology at Emory University School of Medicine in Atlanta. While participating in this residency, Plaintiff purchased a Disability Income Policy from Defendant. 2 The policy provided a monthly income benefit through August 17, 2027 should Plaintiff “suffer a period of disability due to sickness or injury which extends beyond the waiting period,” which was 90 days. (Id. at RLA 2160-61, 2167). The policy defined “disability” as follows: “You have a disability if, because of continuing sickness or injury, you: (1) are under the regular, reasonable and customary care of a physician; and (2) are unable to engage in your regular occupation.... ” (Id. at RLA 2166). The policy defined “regular *1379 occupation” as “[t]he primary income-producing duties you engage in at the time you become disabled.” (Id.). Additionally, the policy provided that Plaintiff was “unable to engage in your regular occupation when because of continuing disability you are earning not more than 30% of your prior average earned income from your regular occupation.” (Id. at RLA 2166). It is undisputed that Plaintiff was insured as an anesthesiologist under the policy.

After completing the residency program at Emmy and passing written anesthesiology board examinations, Plaintiff began practicing anesthesiology. In May 1994, Plaintiff was hired as a Staff Anesthesiologist at Anesthesia Associates of Hampton, Ltd. (“Associates”), located in Virginia. In that position, Plaintiff enjoyed staff privileges at Sentara Hampton General Hospital (“Sentara”). In June 1994, shortly after commencing his employment with Associates, Plaintiff began abusing Fenta-nyl. Fentanyl is a Schedule II controlled substance typically used in operating rooms to control pain. In addition to relieving pain, however, Fentanyl provides the user with a sense of euphoria, sedation, and freeness. It also causes a craving for the drug as the effects of the medication wear off. During the period from June 1994 to August 17, 1994, Plaintiff used Fentanyl between six and twelve times. (Allen Depo., pp. 31, 37-39). Toward the end of this period, Plaintiff was using the drug in intervals of approximately forty-eight hours. (Id. at 39). It is undisputed that Plaintiffs use of Fentanyl had at this point become an addictive disorder. 3

In late August 1994, Plaintiff was requested to attend a meeting at work, where police officers and officials from the Virginia Board of Medicine were waiting. Plaintiff was apparently questioned about missing quantities of Fentanyl and was unable to offer an adequate explanation. On or about August 25, 1994, Sentara suspended Plaintiffs staff privileges pending an investigation of a possible diversion of a Schedule II controlled substance. On that same date, Plaintiff submitted to a toxicology screen of his urine, which tested positive for Fentanyl. The Virginia Board of Medicine summarily suspended Plaintiffs license to practice in Virginia on September 1, 1994, and Plaintiff was admitted to the William J. Farley Institute for Recovery (“Farley”) the next day. Plaintiffs admission diagnosis included opiate dependence. Plaintiff resided -at Farley and received treatment until his discharge on November 23, 1994. Plaintiffs final diagnosis included opiate dependence, alcohol dependence, and depressive disorder. Nonetheless, his prognosis for recovery was considered good, provided that he strictly adhere to a relapse prevention plan and a continuing care plan. After his discharge from Farley, Plaintiff entered into an Aftercare Agreement with the Medical Society of Virginia’s Physicians Health and Effectiveness Program, and he continued outpatient treatment at Farley.

On November 20, 1994, while he was still in treatment at Farley, Plaintiff submitted a claim for benefits under the Disability Income Policy he had purchased from Defendant. On the claim form, Plaintiff indicated that his disability was “chemical dependency (opiate) & depression,” and that the sickness started on August 25, 1994. (Def. Ex. B). In Janu *1380 ary 1995, Dr. Eric B. Hedberg, Plaintiffs treating physician at Farley, completed a statement of disability for Plaintiff. Dr. Hedberg’s statement indicated that Plaintiff suffered from opiate dependence and was unable to perform his regular work. (Def.Ex. C., pp. 1-2). The statement also indicated, with regard to physical impairment, that Plaintiff had ,“[n]o limitations of functional capacity; capable of heavy work; no restrictions.” (Def.Ex. C., p. 1). The statement further indicated, with regard to mental impairment, that Plaintiff “is able to function under stress and engage in interpersonal relations (no limitations).” (Id. at 2). Finally, in answering whether he expected a fundamental or marked change in the future relating to Plaintiffs job, Dr. Hedberg marked “Yes — Improvement.” (Id.).

On March 7, 1995, the Virginia Board of Medicine indefinitely continued the suspension of Plaintiffs license, although it stayed the suspension upon certain conditions. One of these conditions was that Plaintiffs medical practice be confined to a residency or fellowship program approved by the Board. Additionally, Plaintiff was not to prescribe, dispense, or administer any Schedule II controlled substances.

Plaintiff began a residency program in internal medicine in May 1995. Shortly after beginning this residency, complaints arose that Plaintiff was administering narcotics to patients and tests showed the possible presence of blocking agents in Plaintiffs urine samples. Plaintiff, however, never used any blocking agents. (Allen Depo., p. 57). The monitoring physician assigned to Plaintiff through the Aftercare Agreement recommended that Plaintiff return to Atlanta for treatment at the Tal-bott Marsh Recovery Center (“TMRC”).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Berry v. Paul Revere Life Insurance Co.
21 So. 3d 385 (Louisiana Court of Appeal, 2009)
Colby v. Assurant Employee Benefits
603 F. Supp. 2d 223 (D. Massachusetts, 2009)
Stanford v. Continental Casualty Co.
514 F.3d 354 (Fourth Circuit, 2008)
Stanford v. Continental Casualty Company
455 F. Supp. 2d 438 (E.D. North Carolina, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
216 F. Supp. 2d 1377, 2001 U.S. Dist. LEXIS 10460, 2001 WL 1898261, Counsel Stack Legal Research, https://law.counselstack.com/opinion/allen-v-minnesota-life-insurance-gand-2001.